Digital Transformation in the Pharmaceutical Industry

Price: Starting at USD 3,000
Publish Date: 24 Feb 2021
Code: AN-5422
Research Type: Research Report
Pages: 26
Digital Transformation in the Pharmaceutical Industry
Actionable Benefits

Actionable Benefits

  • Provides a holistic overview of the pharmaceutical industry to reveal investment priorities.
  • Understand the short and mid-term market impacts of COVID-19 on pharmaceutical manufacturers’ technology investments.
  • Identify use cases that are driving growth in pharmaceutical manufacturers’ adoption of Industry 4.0 technologies.
  • Map the progress made by pharmaceutical clients regarding the utilization of Industry 4.0 technologies on ABI Research’s Digital Maturity Model.
Critical Questions Answered

Critical Questions Answered

  • What are the current and future trends concerning technology adoption by pharmaceutical manufacturers?
  • What is the influence of regulators both in terms of compliance and their encouragement of investments in digital technologies?
  • What issues inhibit pharmaceutical manufacturers to invest in digital technologies and potential ways they could be overcome?
  • Who are some of technology suppliers that focus on addressing the specific needs of pharmaceutical manufacturers?
Research Highlights

Research Highlights

  • Strategic recommendations about engaging with pharmaceutical manufacturers.
  • A detailed assessment of spend by pharmaceutical manufacturers on digital technologies through 2030.
  • Case studies covering how manufacturers have utilized digital technologies.
  • Understand the types of suppliers looking to help pharmaceutical manufacturers digitize processes and optimize production.
Who Should Read This?

Who Should Read This?

  • Strategists responsible for improving how their organizations engage with the pharmaceutical industry.
  • System integrators that need to evaluate potential solutions at their client sites.
  • Marketing leaders looking to understand adoption rates for digital technologies.
  • Digital leaders at pharmaceutical firms looking to obtain insights covering how digital technologies can support the manufacturing of drugs and vaccines.

Table of Contents

1. EXECUTIVE SUMMARY

2. INTRODUCTION TO THE PHARMACEUTICAL MARKET

2.1. Regulatory Environment

3. COMPONENTS OF A DIGITAL STRATEGY IN PHARMA MANUFACTURING

4. STRATEGIC GUIDANCE/RECOMMENDATIONS FOR STAKEHOLDERS

4.1. For Pharmaceutical Manufacturers
4.2. For Technology Suppliers

5. INDUSTRY 4.0 DRIVERS

6. INDUSTRY 4.0 INHIBITORS

7. MARKET DEVELOPMENTS

8. FORECASTS

9. PHARMACEUTICAL MANUFACTURING SUPPLIER ECOSYSTEM

9.1. Digitizing Processes
9.2. Optimizing Production Processes

Related Research Spotlight

Pharma Production Digital Transformation

This Spotlight Includes:

Digital Transformation of the Pharmaceutical Supply Chain
Digital Transformation of the Pharmaceutical Supply Chain
Software Suppliers Supporting the Pharmaceuticals Value Chain
Software Suppliers Supporting the Pharmaceuticals Value Chain
IoT and Supply Chain Visibility in the Pharmaceutical Industry: Ecosystem Assessment
IoT and Supply Chain Visibility in the Pharmaceutical Industry: Ecosystem Assessment
Digital Transformation in the Pharmaceutical Industry
Digital Transformation in the Pharmaceutical Industry
+ More Research
  • All recently published research
  • Access to any updates to the research published within six months of purchase
  • Direct insight from our analysts through 60 minutes of Analyst Inquiry
View Spotlight